Genetic polymorphism in pathogenesis of irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 47, 2014, Pages 17693-17698

  Cheung, Cynthia K Y ^a   Wu, Justin C Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokines; Endocannabinoids; Genetic polymorphism; Irritable bowel syndrome; Psychiatric distress; Serotonin

Indexed keywords

CATECHOL METHYLTRANSFERASE; CHOLECYSTOKININ; ENDOCANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN BETA POLYPEPTIDE 3; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; INTERLEUKIN 10; INTERLEUKIN 8; NEUROPEPTIDE S; SEROTONIN; SEROTONIN REUPTAKE TRANSPORTER; SEROTONIN TRANSPORTER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; CYTOKINE; GENETIC MARKER; NEUROPEPTIDE;

ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DISTRESS SYNDROME; GENETIC POLYMORPHISM; HUMAN; IRRITABLE COLON; NONHUMAN; PATHOGENESIS; SEROTONINERGIC SYSTEM; TREATMENT RESPONSE; DEFECATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; IRRITABLE BOWEL SYNDROME; PATHOPHYSIOLOGY; PHENOTYPE; PROGNOSIS; RISK FACTOR;

CYTOKINES; DEFECATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRRITABLE BOWEL SYNDROME; NEUROPEPTIDES; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84919733112     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i47.17693     Document Type: Article

References (65)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/j.gastro.2005.11.061]
2. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15: 237-241 [PMID: 17013448]
3. Kang JY . Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 21: 663-676 [PMID: 15771752 DOI: 10.1111/j.1365-2036.2005.02396.x]
4. Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010; 138: 1276-1285 [PMID: 20176021 DOI: 10.1053/j.gastro.2010.02.037]
5. Curzon G. Serotonin and appetite. Ann N Y Acad Sci 1990; 600: 521-530; discussion 530-531 [PMID: 2252331]
6. Spiller R. Serotonin and GI clinical disorders. Neuropharmacology 2008; 55 : 1072-1080 [PMID: 18687345 DOI: 10.1016/j.neuropharm.2008.07.016]
7. Grundy D. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions. Eur Rev Med Pharmacol Sci 2008; 12 Suppl 1: 63-67 [PMID: 18924445]
8. Cheung CK, Lee YY, Chan Y, Cheong PK, Law WT, Lee SF, Sung JJ, Chan FK, Wu JC. Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2013; 11: 1125-1129 [PMID: 23591288 DOI: 10.1016/j.cgh.2013.03.026]
9. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003; 52: 663-670 [PMID: 12692050]
10. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34-43 [PMID: 16401466 DOI: 10.1053/j.gastro.2005.09.031]
11. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-46 [PMID: 9505884]
12. Lovenberg W, Jequier E, Sjoerdsma A. Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor. Science 1967; 155: 217-219 [PMID: 6015530]
13. Ledley FD, Grenett HE, Bartos DP, van Tuinen P, Ledbetter DH, Woo SL. Assignment of human tryptophan hydroxylase locus to chromosome 11: gene duplication and translocation in evolution of aromatic amino acid hydroxylases. Somat Cell Mol Genet 1987; 13: 575-580 [PMID: 2889273]
14. Zill P, Baghai TC, Zwanzger P, Schüle C, Eser D, Rupprecht R, Möller HJ, Bondy B, Ackenheil M. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004; 9 : 1030-1036 [PMID: 15124006 DOI: 10.1038/sj.mp.4001525]
15. Zill P, Büttner A, Eisenmenger W, Möller HJ, Ackenheil M, Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J Psychiatr Res 2007; 41: 168-173 [PMID: 16023677 DOI: 10.1016/j.jpsychires.2005.05.004]
16. Jun S, Kohen R, Cain KC, Jarrett ME, Heitkemper MM. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2011; 23: 233-239, e116 [PMID: 21073637 DOI: 10.1111/j.1365-2982.2010.01623.x]
17. Wang YM, Chang Y, Chang YY, Cheng J, Li J, Wang T, Zhang QY, Liang DC, Sun B, Wang BM. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients. Neurogastroenterol Motil 2012; 24: 560-565, e254-e255 [PMID: 22435794 DOI: 10.1111/j.1365-2982.2012.01902.x]
18. Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B, Crocker N, Rallan R, Varsani S, Montgomery D, Alpers DH, Dukes GE, Purvis I, Hicks GA. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452-1458 [PMID: 15361494 DOI: 10.1136/gut.2003.035451]
19. Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 2009; 47: 946-951 [PMID: 19426812 DOI: 10.1016/j.neuroimage.2009.04.083]
20. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002; 123: 425-432 [PMID: 12145795]
21. Kohen R, Jarrett ME, Cain KC, Jun SE, Navaja GP, Symonds S, Heitkemper MM. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci 2009; 54: 2663-2670 [PMID: 19125330 DOI: 10.1007/s10620-008-0666-3]
22. Jarrett ME, Kohen R, Cain KC, Burr RL, Poppe A, Navaja GP, Heitkemper MM. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs 2007; 9: 161-169 [PMID: 17909168 DOI: 10.1177/1099800407307822]
23. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004; 127B: 85-89 [PMID: 15108187 DOI: 10.1002/ajmg.b.20158]
24. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2008; 295: G219-G225 [PMID: 18511740 DOI: 10.1152/ajpgi.90202.2008]
25. Choi YJ, Hwang SW, Kim N, Park JH, Oh JC, Lee DH. Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C& gt; G and Irritable Bowel Syndrome in Korea. J Neurogastroenterol Motil 2014; 20: 388-399 [PMID: 24917480 DOI: 10.5056/jnm14020]
26. Mujakovic S, ter Linde JJ, de Wit NJ, van Marrewijk CJ, Fransen GA, Onland-Moret NC, Laheij RJ, Muris JW, Grobbee DE, Samsom M, Jansen JB, Knottnerus A, Numans ME. Serotonin receptor 3A polymorphism c.-42C & gt; T is associated with severe dyspepsia. BMC Med Genet 2011; 12: 140 [PMID: 22014438 DOI: 10.1186/1471-2350-12-140]
27. Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA. The HTR3A polymorphism c. -42C& gt; T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology 2011; 140: 1943-1951 [PMID: 21420406 DOI: 10.1053/j.gastro.2011.03.011]
28. Tokunaga A, Saika M, Senba E. 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 1998; 76: 349-355 [PMID: 9718253]
29. Kim DY, Camilleri M. Serotonin: a mediator of the braingut connection. Am J Gastroenterol 2000; 95: 2698-2709 [PMID: 11051338 DOI: 10.1111/j.1572-0241.2000.03177.x]
30. Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Karamanolis DG. 5-HT2A receptor gene polymorphisms and irritable bowel syndrome. J Clin Gastroenterol 2011; 45: 514-517 [PMID: 21325954 DOI: 10.1097/MCG.0b013e318205e13b]
31. Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O. Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol 2004; 38: 561-566 [PMID: 15232358]
32. Cremonini F, Camilleri M, McKinzie S, Carlson P, Camilleri CE, Burton D, Thomforde G, Urrutia R, Zinsmeister AR. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol 2005; 100: 652-663 [PMID: 15743365 DOI: 10.1111/j.1572-0241.2005.41081.x]
33. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M, Hausken T. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 883-891 [PMID: 20132151 DOI: 10.1111/j.1365-2036.2010.04251.x]
34. Park SY, Rew JS, Lee SM, Ki HS, Lee KR, Cheo JH, Kim HI, Noh DY, Joo YE, Kim HS, Choi SK. Association of CCK(1) Receptor Gene Polymorphisms and Irritable Bowel Syndrome in Korean. J Neurogastroenterol Motil 2010; 16: 71-76 [PMID: 20535329 DOI: 10.5056/jnm.2010.16.1.71]
35. Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003; 23: 104-107 [PMID: 12739038 DOI: 10.1007/s00296-002-0260-5]
36. Domschke K, Deckert J, O'donovan MC, Glatt SJ. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 667-673 [PMID: 17357147 DOI: 10.1002/ajmg.b.30494]
37. Karling P, Danielsson A, Wikgren M, Söderström I, Del-Favero J, Adolfsson R, Norrback KF. The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One 2011; 6: e18035 [PMID: 21437260 DOI: 10.1371/journal.pone.0018035]
38. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491 : 56-65 [PMID: 23128226 DOI: 10.1038/nature11632]
39. Lee HJ, Lee SY, Choi JE, Kim JH, Sung IK, Park HS, Jin CJ. G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 758-763 [PMID: 20337945 DOI: 10.1111/j.1365-2982.2010.01496.x]
40. Kim HG, Lee KJ, Lim SG, Jung JY, Cho SW. G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil 2012; 18: 205-210 [PMID: 22523731 DOI: 10.5056/jnm.2012.18.2.205]
41. Tahara T, Arisawa T, Shibata T, Wang F, Nakamura M, Sakata M, Hirata I, Nakano H. Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia. Dig Dis Sci 2008; 53: 642-646 [PMID: 17717746 DOI: 10.1007/s10620-007-9923-0]
42. Oshima T, Nakajima S, Yokoyama T, Toyoshima F, Sakurai J, Tanaka J, Tomita T, Kim Y, Hori K, Matsumoto T, Miwa H. The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet 2010; 11: 13 [PMID: 20102604 DOI: 10.1186/1471-2350-11-13]
43. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNβ3 825C& gt; T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci 2012; 57: 2650-2657 [PMID: 22855291 DOI: 10.1007/s10620-012-2319-9]
44. Guindon J, Hohmann AG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 2009; 8: 403-421 [PMID: 19839937]
45. Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil 2012; 24 : 358-e169 [PMID: 22288893 DOI: 10.1111/j.1365-2982.2011.01874.x]
46. Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol 2013; 304: G553-G560 [PMID: 23306084 DOI: 10.1152/ajpgi.00376.2012]
47. Park JM, Choi MG, Cho YK, Lee IS, Kim SW, Choi KY, Chung IS. Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. J Clin Gastroenterol 2011; 45: 45-49 [PMID: 20505532 DOI: 10.1097/MCG.0b013e3181dd1573]
48. Klengel T, Binder EB. Gene-environment interactions in major depressive disorder. Can J Psychiatry 2013; 58: 76-83 [PMID: 23442893]
49. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447-1458 [PMID: 16678558 DOI: 10.1053/j.gastro.2005.11.057]
50. Drossman DA. Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol 1996; 22: 252-254 [PMID: 8771417]
51. Kabra N, Nadkarni A. Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J Psychiatry 2013; 55: 77-80 [PMID: 23439939 DOI: 10.4103/0019-5545.105520]
52. Lee S, Wu J, Ma YL, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther 2009; 30: 643-651 [PMID: 19552631 DOI: 10.1111/j.1365-2036.2009.04074.x]
53. Sato N, Suzuki N, Sasaki A, Aizawa E, Obayashi T, Kanazawa M, Mizuno T, Kano M, Aoki M, Fukudo S. Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome. PLoS One 2012; 7: e42450 [PMID: 22957021 DOI: 10.1371/journal.pone.0042450]
54. Raiteri L, Luccini E, Romei C, Salvadori S, Calò G. Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. Br J Pharmacol 2009; 157: 474-481 [PMID: 19371348 DOI: 10.1111/j.1476-5381.2009.00163.x]
55. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology 2010; 138: 98-107.e4 [PMID: 19732772 DOI: 10.1053/j.gastro.2009.08.051]
56. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O' Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006; 130: 304-311 [PMID: 16472586 DOI: 10.1053/j.gastro.2005.11.033]
57. Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 1205-1212 [PMID: 19367268 DOI: 10.1038/ajg.2009.116]
58. Santhosh S, Dutta AK, Samuel P, Joseph AJ, Ashok Kumar J, Kurian G. Cytokine gene polymorphisms in irritable bowel syndrome in Indian population-a pilot case control study. Trop Gastroenterol 2010; 31: 30-33 [PMID: 20860222]
59. Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR, Mahmoudi M, Keramati MR, Habibollahi P, Bashashati M, Ebrahimi-Daryani N, Amirzargar AA. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010; 30: 74-79 [PMID: 19844779 DOI: 10.1007/s10875-009-9342-4]
60. Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Törkvist L, Schmidt PT, Karling P, Ohlsson B, Duerr RH, Simren M, Lindberg G, Agreus L, Carlson P, Zinsmeister AR, D'Amato M. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011; 60: 1671-1677 [PMID: 21636646 DOI: 10.1136/gut.2011.241877]
61. Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, Yang YS, Yun KJ. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cells 2010; 29: 21-28 [PMID: 20016944 DOI: 10.1007/s10059-010-0002-6]
62. Camilleri M, Carlson P, McKinzie S, Zucchelli M, D'Amato M, Busciglio I, Burton D, Zinsmeister AR. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil 2011; 23: 935-e398 [PMID: 21752155 DOI: 10.1111/j.1365-2982.2011.01749.x]
63. Romero-Valdovinos M, Gudiño-Ramírez A, Reyes-Gordillo J, Martínez-Flores WA, Ramírez-Miranda ME, Maravilla P, Olivo-Díaz A. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Mol Biol Rep 2012; 39: 8837-8843 [PMID: 22740130 DOI: 10.1007/s11033-012-1745-2]
64. Olivo-Diaz A, Romero-Valdovinos M, Gudiño-Ramirez A, Reyes-Gordillo J, Jimenez-Gonzalez DE, Ramirez-Miranda ME, Martinez-Flores WA, Martinez-Hernandez F, Flisser A, Maravilla P. Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol Res 2012; 111: 487-491 [PMID: 22287022 DOI: 10.1007/s00436-012-2830-0]
65. Sun X, Lan C, An Y, Sun Y. Colonic expression of Runx3 protein and TGF-β(1) and their correlation in patients with irritable bowel syndrome. Asian Pac J Trop Med 2011; 4: 547-549 [PMID: 21803306 DOI: 10.1016/S1995-7645(11)60143-0]